• Mission
• Strategy
• Team
  • > Management
  • > Board of Directors
  • > Advisors

Home > Company > Strategy

Strategy

In order to develop innovative and clinically useful diagnostic tools, IntegraGen controls the entire Genomic Diagnostics Services development chain:

• Technological leadership and command of state-of-the-art genomics, particularly command of technologies such as high bit-rate sequencing and genotyping and, in more general terms, all technologies relative to analysis of DNA and genetic cell material.
• Integration of academic or private research into the networks as partner or service provider.
• Establishment of networks of clinical practitioners specialised in targeted pathologies where the tools developed serve to improve patient care.
• Control of the biostatistics and bioinformatics validation aspects.
• Perfect knowledge of regulatory aspects.
• Access to reference laboratory markets in Europe and North America.

IntegraGen’s vocation is to be number 1 in the genetic test field, thus contributing to diagnostics and improving care for targeted pathologies such as autism and certain forms of cancer.